Why less might be more when it comes to bisphosphonates

New evidence adds to concerns about the benefits of long-term use
elderly woman

New evidence has added to concerns about the benefit of very long-term bisphosphonate use.

An analysis of more than 5120 postmenopausal women — the largest to assess fracture risk in older, female, long-term bisphosphonate users — supports discontinuing therapy after 2-5 years.